Sun Pharmaceuticals Industries - M&A Summary and Business Overview

Life ScienceCompany

Sun Pharmaceuticals Industries M&A Summary

Sun Pharmaceuticals Industries has acquired 14 companies, including 1 in the last 5 years.

Sun Pharmaceuticals Industries’ largest acquisition to date was in 2014, when it acquired Ranbaxy Laboratories for $4.0B. Sun Pharmaceuticals Industries has acquired in 3 different US states, and 6 countries. The Company’s most targeted sectors include life science (65%) and medical products (36%).

Sun Pharmaceuticals Industries Business Overview

Where is Sun Pharmaceuticals Industries headquartered?

Sun Pharmaceuticals Industries is headquartered in Mumbai, India.

What is Sun Pharmaceuticals Industries’ revenue?

Sun Pharmaceuticals Industries disclosed revenue of 384,264M INR for 2022 and 331,392M INR for 2021.

How many employees does Sun Pharmaceuticals Industries have?

Sun Pharmaceuticals Industries has 37,000 employees.

What sector is Sun Pharmaceuticals Industries in?

Sun Pharmaceuticals Industries is a life science company.

When was Sun Pharmaceuticals Industries founded?

Sun Pharmaceuticals Industries was founded in 1983.

M&A Summary

  • M&A Total Activity14
    • M&A Buy Activity14
  • Total Sectors Invested 2
  • Total Countries Invested 6
  • M&A Buy/Sell Connections 2
  • M&A Advisors 7

Sun Pharmaceuticals Industries

Sun Pharmaceuticals Industries Ltd.

Sun House Plot No. 201 B/1 Western Express Highway Goregaon (East),
Mumbai, 400063
India,
+91 22 4324 4324
www.sunpharma.com

Sun Pharmaceuticals Industries is a specialty generic pharmaceutical company. Products are sold through drug stores, mass merchants, grocery stores and gift/specialty stores. Sun Pharmaceuticals Industries was founded in 1983 and is based in Mumbai, India.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.2/yr) # 13 - - - 1 - 14
vol $4.7B $576M $5.3B
Sell (0.0/yr) # - - - - - - 0
  14

Most Recent M&A

Company Date Value Type
Concert Pharmaceuticals, Inc. 2023-01-19 576M USD Add-on Acquisition
Lexington, Massachusetts · www.concertpharma.com
Pola Pharma, Inc. (POLA-Pharma) 2018-11-27 1M USD Add-on Acquisition
Shinagawa, Japan · www.pola-pharma.co.jp
JSC Biosintez 2016-11-23 - Add-on Acquisition
Penza, Russia · www.biosintez.com
InSite Vision, Inc. 2015-09-17 48M USD Add-on Acquisition
Alameda, California · www.insitevision.com
GlaxoSmithKline - Opiates Business 2015-03-03 - Divestiture
, Australia
Pharmalucence, Inc. 2014-07-16 - Add-on Acquisition
Bedford, Massachusetts · www.pharmalucence.com
Ranbaxy Laboratories Ltd. 2014-04-04 4.0B USD Divestiture
New Delhi, India · www.ranbaxy.com
DUSA Pharmaceuticals Inc. 2012-12-20 230M USD Add-on Acquisition
Wilmington, Massachusetts · www.dusapharma.com
Caraco Pharmaceutical Laboratories Ltd. 2011-02-23 - Stake Purchase
Detroit, Michigan
Taro Pharmaceutical Industries Ltd. 2007-05-21 454M USD Stake Purchase
Haifa Bay, Israel · www.taro.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 9 (64%) 5.1B (96%) - -
Medical Products 5 (36%) 230M (4%) - -
Total 14 $5.3B - -

By Geo

State/Country Buy Value Sell Value
United States 6 854M - -
  Massachusetts 3 806M - -
  Michigan 2 - - -
  California 1 48M - -
India 4 4.0B - -
Australia 1 - - -
Israel 1 454M - -
Japan 1 1M - -
Russia 1 - - -
Domestic 4 (29%) 4.0B (75%) - -
Cross-border 10 (71%) 1.3B (25%) - -
Total 14 $5.3B - -

Top M&A Advisors

Financial Deals
Citigroup Investment Banking
 1
Evercore Group
 1
Moelis & Co.
 1
Legal Deals
Shearman & Sterling
 1
Crawford Bayley & Co.
 1
S. H. Bathiya & Associates LLP
 1

Deal Values

buy # Total
> $1B 1 $4.0B
$100M to $1B 3 $1.3B
< $100M 2 $49M
TOTAL $5.3B
Largest Ranbaxy Laboratories Ltd.
$4.0B (2014-04-04)

M&A Connections

Deals
Acquired from
Strategic(s)
14%
2 (14%)

Company Summary

SECTOR

Life Science

Revenue

384,264   16% 2022
331,392   3% 2021
323,252   13% 2020
286,863   9% 2019
264,885   16% 2018
313,081   2017
(millions of INR) Show More Show Less

Employees

37,000

Established

1983

Public

National Stock Exchange of India (NSE): SUNPHARMA

 Subscribe to unlock this and 201,535
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Sun Pharmaceuticals Industries

Life Science Companies , India Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for India Companies

Largest India Companies , Acquisitive India Companies , Recently Acquired India Companies , Recently Sold India Companies , Private India Companies , Public India Companies , Acquired India Companies , PE Backed India Companies
Mergr

Product

Company

Legal